Latest News and Press Releases
Want to stay updated on the latest news?
-
DENVER, CO--(Marketwire - September 8, 2009) - Dean Evans & Associates, Inc. (www.dea.com) today outlined the new functionality in an update to their popular EMS Campus academic scheduling and...
-
SAN JOSE, CA--(Marketwire - September 8, 2009) - Interface Masters Technologies, an industry leader and innovator in networking solutions, has announced additional members of its Gigabit Ethernet...
-
The offering at the refinancing auctions in September amounts to DKK 24bn worth of covered bonds. This is DKK 2.1bn less than announced in the stock exchange announcement issued on 19 August 2009....
-
WORCESTER, Mass., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
-
Ariston Real Estate AG / Preliminary announcement on the disclosure of financial statements 08.09.2009 Announcement according to articles 37v, 37w, 37x ff. WpHG, transmitted by DGAP - a company of...
-
To read the complete press release, please see www.tevapharm.com. For further information, please contact: Tomas Leanderson, President & CEO Tel: +46 46 19 20 95 E-mail:...
-
Lund, Sweden, September 8, 2009 - Active Biotech AB's (NASDAQ OMX Nordic: ACTI) collaboration partner Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announce information regarding the...
-
The offering at the refinancing auctions in September amounts to DKK 24bn worth of covered bonds. This is DKK 2.1bn less than announced in the stock exchange announcement issued on 19 August 2009....
-
För att läsa hela pressmeddelandet, se www.tevapharm.com. För ytterligare information, vänligen kontakta: Tomas Leanderson, President & CEO Tel: 046 19 20 95 E-mail:...
-
Lund den 8 september 2009 - Active Biotech AB:s (NASDAQ OMX Nordic: ACTI) samarbetspartner Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) offentliggör idag information kring de nya data som...